» Articles » PMID: 19690809

Increasing M2 Epitope Density Enhances Systemic and Mucosal Immune Responses to Influenza A Virus

Overview
Journal Biotechnol Lett
Date 2009 Aug 20
PMID 19690809
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant proteins bearing one (sM2) or three (3sM2) copies of M2 epitope from influenza virus were expressed in Escherichia coli. Mice were administrated with these two proteins and systemic and mucosal immune responses were analyzed. Compared with sM2, 3sM2 induced M2-specific serum IgG and mucosal IgA antibodies with neutralizing activity more efficiently in the whole immune course and the later mucosal immunization improved this advantage. MDCK cells pretreated with 3sM2 antisera showed less pathogenic morphological changes compared with that of pretreated with sM2. Together, our results demonstrated that high epitope density in one recombinant protein can enhance humoral immune responses in both systemic and mucosal immunization, and combination of systemic and mucosal immunization enhances this advantage.

Citing Articles

A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa.

Reza Rahbar M, Mubarak S, Hessami A, Khalesi B, Pourzardosht N, Khalili S Sci Rep. 2022; 12(1):10852.

PMID: 35760825 PMC: 9237110. DOI: 10.1038/s41598-022-14877-5.


Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.

Lee Y, Ko E, Lee Y, Kim K, Kim M, Lee Y PLoS One. 2018; 13(1):e0190868.

PMID: 29324805 PMC: 5764335. DOI: 10.1371/journal.pone.0190868.


New vaccines against influenza virus.

Lee Y, Kim K, Ko E, Lee Y, Kim M, Kwon Y Clin Exp Vaccine Res. 2014; 3(1):12-28.

PMID: 24427759 PMC: 3890446. DOI: 10.7774/cevr.2014.3.1.12.


Virus-like particles as universal influenza vaccines.

Kang S, Kim M, Compans R Expert Rev Vaccines. 2012; 11(8):995-1007.

PMID: 23002980 PMC: 3513402. DOI: 10.1586/erv.12.70.